What is it about?
This research explores how people judge and assign responsibility to people living with HIV (PLHIV) based on the mode of transmission. It examines whether cases resulting from non-normative behaviours (e.g., drug use, homosexual contact) are judged more harshly than those resulting from normative behaviours (e.g., heterosexual contact, blood transfusion).
Featured Image
Photo by Ubaid E. Alyafizi on Unsplash
Why is it important?
Despite medical progress, HIV-related stigma persists. The study reveals that judgments about PLHIV are still heavily influenced by moral beliefs, social norms, and the perceived "deviance" of the transmission route. These factors affect both the degree of responsibility attributed to PLHIV and the willingness to engage with them socially.
Perspectives
What struck me most while working on this study was how deeply moral beliefs and social norms continue to shape attitudes toward people living with HIV. Despite decades of public health campaigns and biomedical progress, stigma remains entangled with ideas of "deservingness" and "blame." As an academic teacher and researcher, I find this particularly concerning given that our participants were future teachers. Their judgments may not stay in the classroom, as they can shape how children perceive health, sexuality, and diversity. This highlights the urgent need to integrate comprehensive sexuality education and diversity training into university curricula for future teaching professionals, particularly those preparing to work in primary education. I hope this work helps shift not only individual attitudes but also institutional priorities, so that responsibility is no longer mistaken for morality and care is no longer treated as conditional.
Dr Chrysovalantis Papathanasiou
Panteion Panepistemio Koinonikon kai Politikon Epistemon
Read the Original
This page is a summary of: The ‘how’ of HIV infection matters: social judgments and responsibility attribution in the context of the AIDS epidemic, Sociology International Journal, August 2022, MedCrave Group LLC,
DOI: 10.15406/sij.2022.06.00289.
You can read the full text:
Contributors
The following have contributed to this page







